AmebaGone Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$100K
- Investors
-
10
AmebaGone General Information
Description
Developer of amoebae technologies designed to destroy intractable bacterial infections in crops. The company uses naturally occurring free-living phagocytic dictyostelid cells and their secreted products as bio-control chemicals to kill bacteria, enabling agricultural farmers and industries to treat disease-causing bacteria in plants, humans, and the environment.
Contact Information
Website
www.amebagone.comCorporate Office
- 505 South Rosa Road
- Suite Number 15
- Madison, WI 53719
- United States
Corporate Office
- 505 South Rosa Road
- Suite Number 15
- Madison, WI 53719
- United States
AmebaGone Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Grant | 29-Sep-2020 | $100K | Completed | Generating Revenue | ||
| 10. Grant | 31-Dec-2019 | Completed | Generating Revenue | |||
| 9. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 8. Grant | 31-Dec-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 05-Oct-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 11-Sep-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 01-Mar-2016 | Completed | Generating Revenue | |||
| 4. Debt - General | 01-Jan-2016 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2016 | Completed | Generating Revenue | |||
| 2. Grant | 01-Mar-2015 | $721K | Completed | Startup |
AmebaGone Patents
AmebaGone Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12773430-B2 | Anti-biofilm agents and uses thereof | Active | 23-Apr-2020 | ||
| US-20210330715-A1 | Anti-biofilm agents and uses thereof | Active | 23-Apr-2020 | ||
| EP-4081230-A1 | Therapeutic amoeba and uses thereof | Inactive | 23-Dec-2019 | ||
| EP-4081230-A4 | Therapeutic amoeba and uses thereof | Inactive | 23-Dec-2019 | ||
| US-20230040339-A1 | Therapeutic amoeba and uses thereof | Inactive | 23-Dec-2019 | A01N63/10 |
AmebaGone Signals
AmebaGone Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The Center for Technology Commercialization | Government | |||
| Department of Primary Industries and Regional Development | Government | |||
| National Institutes of Health | Government | |||
| U.S. Department of Health and Human Services | Government | |||
| United States Department of Agriculture | Government |
AmebaGone FAQs
-
When was AmebaGone founded?
AmebaGone was founded in 2010.
-
Where is AmebaGone headquartered?
AmebaGone is headquartered in Madison, WI.
-
What is the size of AmebaGone?
AmebaGone has 6 total employees.
-
What industry is AmebaGone in?
AmebaGone’s primary industry is Biotechnology.
-
Is AmebaGone a private or public company?
AmebaGone is a Private company.
-
What is AmebaGone’s current revenue?
The current revenue for AmebaGone is .
-
How much funding has AmebaGone raised over time?
AmebaGone has raised $10M.
-
Who are AmebaGone’s investors?
The Center for Technology Commercialization, Department of Primary Industries and Regional Development, National Institutes of Health, U.S. Department of Health and Human Services, and United States Department of Agriculture are 5 of 10 investors who have invested in AmebaGone.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process